Skip to content

Effect of Kimchi Capsule on Cortisol Changes in Working Age Volunteers

Effect of Kimchi Capsule on Stress Index in Working Age Volunteers

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20221215001
Enrollment
60
Registered
2022-12-15
Start date
2023-03-07
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy condition Kimchi Capsule Stress Index Cortisol Working age

Interventions

Subjects received the placebo product which has the same color and smell and looks like Kimchi capsules.,Subjects received capsules containing Kimchi powder 2 g per day.,Subjects received capsules con
Placebo,Kimchi capsules 2 g/day,Kimchi capsules 4 g/day

Sponsors

Agricultural Research Development Agency (Public Organization)
Lead Sponsor
MK Restaurant Group Public Company Limited
Collaborator

Eligibility

Sex/Gender
All
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 20-55 years old 2.Body Mass Index (BMI) 18.5-25 kg/m2 3. Can read and write Thai language

Exclusion criteria

Exclusion criteria: 1. Volunteers who have been diagnosed with one of the following; heart disease, lung disease or allergies, diabetes, high blood pressure, liver disease, kidney disease, head injury, and mental disorder. 2. Volunteers who use antibiotics in the last one week before study. 3. Volunteers who use supplement contain probiotics in the last three months before study. 4. Volunteers who have been Hysterectomy and/or Oophorectomy. 5. Volunteers who use hormone or any drug that effect on Hypothalamic Pituitary Gonadal axis, Hypothalamic Pituitary Adrenal, and Hypothalamic Pituitary Thyroid axis. 6. Volunteers who require supplements or any drug that effect on the nervous system by order of the doctor before the start of the test. 7. Drinking alcohol more than 5 times per day 8. Smoking more than 10 pieces per day 9. Volunteers who participate in other projects.

Design outcomes

Primary

MeasureTime frame
The changes of cortisol level 2 months laboratory

Secondary

MeasureTime frame
The changes of amylase level 2 months laboratory,The changes of hematological and clinical chemistry parameters 2 months laboratory,Evaluation of Neurotransmitters; Monoamine oxidase (MAO), Monoamine oxidase type A and type B 2 months laboratory,Stool examination; PH, Lactobacillus spp., Bifidobacterium spp., and Short chain fatty acid 2 months laboratory,The changes of Electrocardiogram 2 months Electrocardiography,Depression Anxiety and Stress Scale - 21 (DASS-21) 2 months questionnaire

Countries

Thailand

Contacts

Public ContactPoonsri Rangseekajee

Faculty of Medicine, Khon Kaen University

poonsri@kku.ac.th66815456669

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026